Whistleblower lawsuits and False Claims Act cases alleging various types of health care fraud produced recoveries to the federal government of $2.6 billion is 2013.
Also prominent among whistleblower lawsuits favorably resolved for the federal government in 2013 were cases involving claims of “off-label marketing” by pharmaceutical manufacturers. In these cases, drug companies were alleged to have promoted their products for uses not approved by the U.S. Food and Drug Administration (FDA).
continue to read here
San Francisco, CA (PRWEB) January 02, 2014
In its continuing effort to safeguard expenditures of taxpayer dollars, the United States Justice Department has reported a 2013 recovery of $3.8 billion in settlements and judgments resolving a myriad of whistleblower lawsuits and False Claims Act cases.* Cases involving health care fraud comprised more than one-half of the total reported recovery, or $2.6 million.
The bulk of health care whistleblower and False Claims Act lawsuits involved Medicare and Medicaid fraud. Especially evident within this group of cases were fraud and false claims for pharmaceuticals and medical devices that also included TRICARE, the governmental arm that provides medical benefits for military personnel and their families.Also prominent among whistleblower lawsuits favorably resolved for the federal government in 2013 were cases involving claims of “off-label marketing” by pharmaceutical manufacturers. In these cases, drug companies were alleged to have promoted their products for uses not approved by the U.S. Food and Drug Administration (FDA).
continue to read here